Adjuvant chemotherapy following surgery for adenocarcinoma arising from intraductal papillary mucinous neoplasia and impact on recurrence and survival: ADENO-IPMN study

被引：0
|
作者：
Lucocq, James [1 ]
Pandanaboyana, Sanjay [2 ]
机构：
[1] Royal Infirm Edinburgh NHS Trust, Edinburgh, Scotland
[2] Freeman Rd Hosp, Newcastle Upon Tyne, England
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷
关键词：
D O I：
10.1093/bjs/znae046.109
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O79
引用
收藏
页数：2
相关论文
共 25 条
  • [11] Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data
    Marchegiani, Giovanni
    Andrianello, Stefano
    Dal Borgo, Chiara
    Secchettin, Erica
    Melisi, Davide
    Malleo, Giuseppe
    Bassi, Claudio
    Salvia, Roberto
    HPB, 2019, 21 (05) : 596 - 603
  • [12] Adjuvant therapy (Adj) in intraductal papillary mucinous neoplasm cancer (IPMN-Ca) versus pancreatic ductal adenocarcinoma (PDAC): Comparison of survival analyses.
    Krishna, Kavya
    Krishna, Somashekar Gopala
    Bloomston, Mark
    Muscarella, Peter
    Schmidt, Carl Richard
    Conwell, Darwin
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [13] Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study
    Habib, Joseph R.
    Kinny-Koster, Benedict
    Javed, Ammar A.
    Zelga, Poitr
    Saadat, Lily V.
    Kim, Rachel C.
    Gorris, Myrte
    Allegrini, Valentina
    Watanabe, Shuichi
    Sharib, Jeremy
    Arcerito, Massimo
    Kaiser, Jorg
    Lafaro, Kelly J.
    Tu, Min
    Bhandre, Manish
    Shi, Chanjuan
    Kim, Michael P.
    Correa, Camilo
    Daamen, Lois A.
    Oberstein, Paul E.
    Schmidt, C. Max
    Hanna, Nader N.
    Allen, Peter
    Loos, Martin
    Shrikhande, Shailesh V.
    Molenaar, I. Quintus
    Frigerio, Isabella
    Katz, Matthew H. G.
    Soares, Kevin C.
    Miao, Yi
    Del Chiaro, Marco
    He, Jin
    Hackert, Thilo
    Salvia, Roberto
    Buchler, Markus W.
    Castillo, Carlos Fernandez-del
    Besselink, Marc G.
    Marchegiani, Giovanni
    Wolfgang, Christopher L.
    Verona IPMN Consortium
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (36)
  • [14] A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Yuhi Yoshizaki
    Yoshimasa Gohda
    Fuyuki Inagaki
    Atsuko Kataoka
    Nobuyuki Takemura
    Hideki Miyazaki
    Toru Igari
    Tomomichi Kiyomatsu
    Hideaki Yano
    Norihiro Kokudo
    Clinical Journal of Gastroenterology, 2024, 17 : 188 - 197
  • [15] A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Yoshizaki, Yuhi
    Gohda, Yoshimasa
    Inagaki, Fuyuki
    Kataoka, Atsuko
    Takemura, Nobuyuki
    Miyazaki, Hideki
    Igari, Toru
    Kiyomatsu, Tomomichi
    Yano, Hideaki
    Kokudo, Norihiro
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (01) : 188 - 197
  • [16] The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
    Ghaneh, Paula
    Kleeff, Jorg
    Halloran, Christopher M.
    Raraty, Michael
    Jackson, Richard
    Melling, James
    Jones, Owain
    Palmer, Daniel H.
    Cox, Trevor F.
    Smith, Chloe J.
    O'Reilly, Derek A.
    Izbicki, Jakob R.
    Scarfe, Andrew G.
    Valle, Juan W.
    McDonald, Alexander C.
    Carter, Ross
    Tebbutt, Niall C.
    Goldstein, David
    Padbury, Robert
    Shannon, Jennifer
    Dervenis, Christos
    Glimelius, Bengt
    Deakin, Mark
    Anthoney, Alan
    Lerch, Markus M.
    Mayerle, Julia
    Olah, Attila
    Rawcliffe, Charlotte L.
    Campbell, Fiona
    Strobel, Oliver
    Buechler, Markus W.
    Neoptolemos, John P.
    ANNALS OF SURGERY, 2019, 269 (03) : 520 - 529
  • [17] Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma''
    Petrucciani, Niccolo
    Antolino, Laura
    Moschetta, Giovanni
    Ramacciato, Giovanni
    ANNALS OF SURGERY, 2019, 270 (06) : E129 - E130
  • [18] Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study
    Lin, Hong T.
    Krishna, Somashekar G.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024,
  • [19] Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma-A Swedish nationwide register-based study
    Holmberg, Marcus
    Radkiewicz, Cecilia
    Stromberg, Cecilia
    Oman, Mikael
    Ghorbani, Poya
    Lohr, J. -Matthias
    Sparrelid, Ernesto
    PANCREATOLOGY, 2023, 23 (01) : 90 - 97
  • [20] Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study
    Pu, Ning
    Wu, Wenchuan
    Liu, Siyao
    Xie, Yuqi
    Yin, Hanlin
    Chen, Qiangda
    He, Taochen
    Xu, Zhihang
    Wang, Wenquan
    Yu, Jun
    Liu, Liang
    Lou, Wenhui
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (10) : 3137 - 3146
123